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Summary: C57BL/6 (B6)-derived embryonic stem (ES)
cells are not widely used to generate knockout mice de-
spite the advantage of a well-deﬁned genetic back-
ground because of poor developmental potential. We
newly established serum- and feeder-free B6 ES cells
with full developmental potential by using leukemia
inhibitory factor (LIF) and 6-bromoindirubin-30-oxime
(BIO), a glycogen synthase kinase-3 (GSK3) inhibitor.
BIO treatment signiﬁcantly increased the expression
levels of 364 genes including pluripotency markers such
as Nanog and Klf family. Unexpectedly, by aggregating
or microinjecting those ES cells to each eight-cell-stage
diploid embryo, we stably generated germline-compe-
tent ES-derived mice. Furthermore, founder mice com-
pletely derived from female XO, heterozygous, or homo-
zygous mutant B6 ES cells were directly available for
intercross breeding and phenotypic analysis. We hereby
propose that serum- and feeder-free B6 ES cells stimu-
lated with LIF plus GSK3 inhibitor are valuable for gener-
ating mouse models on B6 background. genesis 47:414–
422, 2009. V V C 2009 Wiley-Liss, Inc.
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INTRODUCTION
The technology to generate knockout (KO) mice has
been one of the most important advances in under-
standing the function of genes of interest (Capecchi,
2001; Evans, 2001; Goldstein, 2001; Smithies, 2001).
The establishment of KO mice requires time-consuming
processes; a particularly laborious step is the acquisition
of germline-competent founder generation mice from
mutant embryonic stem (ES) cells. Generally, the con-
ventional blastocyst injection method provides founder
mice that are only partially derived from mutant ES cells.
If mutant ES cells partially differentiate into germ cells,
the founder mice can transmit the mutation to the next
generation of mice. C57BL/6 (B6)-derived ES cells have a
greater tendency than 129-derived ES cells to lose their
ability to colonize the germline (Auerbach et al., 2000;
Shimizukawa et al., 2005), although B6 strain is pre-
ferred for phenotyping in vivo especially in metabolic
disorder, behavior and cognition, and immune system
studies. Alternatively, the tetraploid embryo complemen-
tation method has been used to generate germline-com-
petent founder mice that are entirely derived from ES
cells. Unfortunately, the founder mice derived from
inbred ES cells, such as the B6 strain, show poor viabil-
ities or abnormalities due to developmental defects
(Eggan et al., 2001; Nagy et al., 1993). The developmen-
tal potential of B6 ES cells seems to be lost during cell
culture in vitro (Eggan et al., 2001), which is dependent
on the serum and feeder cells. One possibility is that the
quality of the serum lot and feeder layers is variable in
each culture, which may cause decreased developmental
potential. Therefore, we speculate that if ES cells are
maintained under serum- and feeder-free conditions,
germline-competent founder mice should be stably gen-
erated even from B6 ES cells. However, ES cell culture
methods without both serum and feeder cells have not
been thoroughly established.
Leukemia inhibitory factor (LIF)/STAT3 signaling is
known to suppress lineage commitment (Cartwright
et al., 2005; Matsuda et al., 1999; Niwa et al., 1998), but
is insufﬁcient for maintaining self-renewal and pluripo-
tency of ES cells under a serum- and feeder-free condi-
tion. ES cells cultured with LIF-containing medium par-
tially and spontaneously differentiate to early primitive
ectoderm cells, which shows that they have a low
ability to contribute to germ cells (Chambers et al.,
2007; Toyooka et al., 2008). These ﬁndings suggest that
other factor(s) contained in the serum and/or produced
by feeder cells may support the undifferentiation of ES
cells.
Additional Supporting Information may be found in the online version of
this article.
*Correspondence to: Yoshitaka Tamai, Tsukuba Research Institute, Banyu
Pharmaceutical Co., Ltd., Okubo 3, Tsukuba, Ibaraki 300-2611, Japan.
E-mail: ronumegeki@yahoo.co.jp
Published online 23 April 2009 in
Wiley InterScience (www.interscience.wiley.com).
DOI: 10.1002/dvg.20514
' 2009 Wiley-Liss, Inc. genesis 47:414–422 (2009)As an attractive candidate instead of serum and feeder
cells, we focused on the inhibition of glycogen synthase
kinase-3 (GSK3) in Wnt/b-catenin signaling, which main-
tains self-renewal and pluripotency in both mouse and
human ES cells cultured in the presence of serum (Sato
et al., 2004; Singla et al., 2006). According to a previous
report, GSK3a/b double-KO ES cells display hyperacti-
vated Wnt/b-catenin signaling, and severely impair dif-
ferentiation into three germ layers (endoderm, ecto-
derm, and mesoderm) (Doble et al., 2007). However, it
has not been examined whether GSK3 inhibition fulﬁlls
the requirement for serum and feeder cells together
with LIF/STAT3 signaling.
In this study, we investigated: (1) whether LIF/STAT3
signaling plus GSK3 inhibition maintain self-renewal and
pluripotency of ES cells cultured in the absence of serum
and feeder layers, and (2) whether germline-competent
founder mice are generated from ES cells, which were
maintained in such culture conditions. In a previous
report, GSK3b deﬁcient embryos were pale and non-via-
ble between E 13.5 and E 14.5 (Hoeﬂich et al., 2000).
We have used 6-bromoindirubin-30-oxime (BIO), a char-
acterized GSK3 inhibitor, for reversible control of GSK3
function.
RESULTS
The Treatment of LIF Plus BIO Enhanced
Self-Renewal and Pluripotency of
Serum- and Feeder-Free B6 ES Cells
C57/BL6J ES cells (TB6-2), which were originally
established by culturing the inner cell mass (ICM) of
blastocyst-stage embryos, were maintained on a feeder
layer in 1000 U/ml LIF plus 15% serum-containing me-
dium as a standard culture method. However, these cells
showed very low developmental potency despite nor-
mal karyotypes (38 1 XY) when aggregated with tetra-
ploid embryos to generate founder mice (2 100% ES-
derived coat-color mice/427 embryos transferred, 0.5%;
Table 1). Tetraploid aggregation method was useful for
the generation of founder mice from B6-derived ES cells
(Shimizukawa et al., 2005). To improve their potency,
we cultured TB6-2 cells on a gelatin-coated plate in 1000
U/ml LIF plus 15% Knockout Serum Replacement (KSR)
medium, and they were maintained under ‘‘serum- and
feeder-free’’ or ‘‘serum- and feeder-independent’’ condi-
tions. Compared with a standard culture system, most
colonies showed alkaline phosphatase activity, whereas
some of them did not (Fig. 1a). This result indicates that
the TB6-2 cells consisted of heterogeneous populations
due to spontaneous differentiation.
To examine whether GSK3 inhibitor can support B6
ES self-renewal without spontaneous differentiation, we
checked colony morphology and alkaline phosphatase
activity in the following cultures: 10 U/ml LIF, 1000 U/
ml LIF, 10 U/ml LIF plus BIO, and 1000 U/ml LIF plus
BIO. After 5 days, in the 1000 U/ml LIF plus BIO culture,
ES colonies showed round shapes and strong activity of
alkaline phosphatase under the serum- and feeder-free
condition (Fig. 1b). These round-shaped colonies
resembled ES colonies that were cultured on a feeder
layer. On the other hand, in the 10 U/ml LIF plus BIO
culture, the number of partially differentiated colonies
gradually increased according to passage number similar
to the 1000 U/ml LIF single culture. Moreover, we exam-
ined the effects of BIO on cell proliferation (Fig. 1c). The
growth speed in BIO-treated cultures was signiﬁcantly
faster than that in BIO-absent cultures, and also LIF addi-
tion enhanced ES cell proliferation. Taken together,
these results indicate that in combination with LIF, GSK3
inhibitor enhances self-renewal, the suppression of
spontaneous differentiation, and cell proliferation even
in the serum- and feeder-free culture.
Next, we investigated a pluripotency marker in the se-
rum- and feeder-free B6 ES cells (Fig. 1d). To examine
the activity of Oct4 (also known as Pou5f1) promoter
containing distal and proximal enhancers, we estab-
lished Oct4-GIN (Oct4 promoter-GFP-IRES-Neo) ES cells,
in which both GFP and neomycin-resistance gene (Neo)
were transcribed by the Oct4 promoter. After the selec-
tion culture with G418, GFP expression was clearly
observed in all living ES colonies stimulated with 1000
U/ml LIF plus BIO (Fig. 1d). However, partial expression
of GFP was found in 1000 U/ml LIF single, 10 U/ml LIF
plus BIO, and 10 U/ml LIF single conditions, respec-
tively. These observations suggest that in concert with
LIF/STAT3 signaling, GSK3 inhibition maintains the se-
rum- and feeder-free B6 ES cells in a pluripotent state.
Expression of Self-Renewal and Pluripotency
Makers was Upregulated by BIO Treatment in
Serum- and Feeder-Free B6 ES Cells
To examine how GSK3 inhibitor enhanced self-
renewal and pluripotency in the serum- and feeder-free
B6 ES cells cultured with LIF (1000 U/ml) alone, we per-
formed DNA microarray analyses (Fig. 2a). In this study,
we identiﬁed 364 upregulated and 788 downregulated
genes (over two-fold) in response to BIO (Tables S1 and
S2). Gene Ontology analysis suggested that BIO func-
tions as a general transcriptional repressor (P-value
5 1.31 3 10
28; Tables S3 and S4). Upon BIO addition,
expression levels of Wnt target genes such as Brachyury
(T) and Cdx1 signiﬁcantly increased, demonstrating that
Wnt/b-catenin signaling was activated as shown in Fig-
ure S1. In the ES cells supported by LIF plus BIO, Nanog
and Klf family members (Klf2, Klf4, and Klf5) of pluripo-
tency markers were approximately three-fold upregu-
lated (Fig. 2a,b). Interestingly, immunocytochemistry
revealed that Nanog signals increased by BIO treatment
in a dose-dependent manner and were also detected not
only in the nucleus but also in the cytoplasm with 5 lM
of BIO treatment (Fig. 2c). In addition, we observed that
BIO stimulation converted the cells from heterogeneous
to homogeneous expression of Nanog, while LIF single
treatment showed heterogeneity as in previous reports
(Chambers et al., 2007; Singh et al., 2007) (Fig. 2c).







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































.Expression levels of Oct4 and Sox2 also slightly
increased to the same level as those in B6/129 F1 hybrid
ES (V6.5) cells cultured with serum and feeder layers
(Fig. 2b). For quantitative RT-PCR analysis, F1 hybrid ES
cells were used as a standard control because of their
high developmental potency to contribute to founder
mice (19 100% ES-derived coat-color mice/270 embryos
transferred, 7.0%; Table 1). Besides the core stemness
genes, BIO treatment signiﬁcantly increased expression
levels of other self-renewal regulators (Tables S1 and S2).
Upon BIO treatment, expression levels of BMP4, Id1,
and Id3 were approximately four-fold upregulated, sug-
gesting that autocrine BMP4 activates Id1 and Id3
expression through the activation of Smad signaling,
which is involved in the inhibition of differentiation to
neuroectoderm (Qi et al., 2004; Ying et al., 2003). In
addition, BIO treatment also signiﬁcantly increased the
expressions of Tbx3, Esrrb, and Tcl1, which have been
newly identiﬁed as self-renewal regulators by the
method of short hairpin RNA (shRNA) loss-of-function
(Ivanova et al., 2006). The overexpressions of Tbx3,
Esrrb, and Tcl1 in BIO-treated ES cells might suppress ES
cell differentiation into neuroectoderm, mesoderm, and
endoderm as in a previous report (Ivanova et al., 2006).
In contrast, expression levels of FGF5, a marker for prim-
itive ectoderm cells, were 10-fold downregulated, sug-
gesting that BIO-treated ES cells are resistant to differen-
tiation stimuli. Consistent with this suggestion, even in
the LIF-absent condition, BIO-treated ES cells had alka-
line phosphatase activity and maintained Oct4 and
Nanog expression (Fig. S2). Taken together, these results
suggest that GSK3 inhibition by BIO efﬁciently enhance
self-renewal and pluripotency by the upregulation of
stemness genes, which form a robust autoregulatory cir-
cuit to maintain ES cells in a self-renewing pluripotent
state.
Germline-Competent ES-Derived Founder Mice
were Stably Generated from Serum- and
Feeder-Free ES Cells in LIF Plus BIO Medium
Because BIO treatment enhanced self-renewal and
pluripotency markers in serum- and feeder-free B6 ES
cells in vitro, we tested their developmental potential by
FIG. 1. Establishment of serum- and feeder-free B6 ES cells by using LIF and BIO. (a) Morphology (left) and alkaline phosphatase activity
(right) of serum- and feeder-free B6 ES cells treated with 1000 U/ml LIF alone. (b) Alkaline phosphatase activity of B6 ES cells cultured for 5
days under the serum- and feeder-free condition. (c) Cell growth assay. Relative cell proliferation was measured as a standard at Day 0.
Error bars are standard deviations (n 5 6). ***P < 0.0001, t-test, between 1000 U/ml LIF and 1000 U/ml LIF plus 2 lM BIO. (d) GFP expres-
sion under Oct4 promoter in serum- and feeder-free B6 ES cells cultured for 5 days. Scale bar: 100 lm.
417 SERUM- AND FEEDER-FREE B6 ES CELLSgenerating founder mice (Table 1). To investigate
whether the production rate of germline-competent
founder mice is improved by using B6 ES cells stimulated
with 1000 U/ml LIF plus BIO, we used the aggregation
method with one eight-cell-stage diploid embryo. At the
beginning of this study, we traced the fate of GFP
expressing B6 ES cells after aggregation. Unexpectedly, a
ﬂuorescent image of the blastocyst showed that GFP in
B6 ES cells was entirely, but not partially, expressed in
the ICM (Fig. S3). This observation indicates that serum-
and feeder-free B6 ES cells cultured in LIF plus BIO had
full potential to contribute to the embryo proper.
Actually, almost all founder mice obtained by the diploid
aggregation method were 100% ES-derived black coat-
color, developed to adults without abnormality, and
exhibited full germline transmission as well as mice
obtained by the tetraploid complementation method (11
100% ES-derived coat-color mice/12 live offsprings,
91.7%; Fig. 3a and Table 1). Similar results were
obtained, when ES cells stimulated with 1000 U/ml LIF
plus BIO were injected into the perivitelline space of
each ICR eight-cell-stage diploid embryo by conventional
or laser-assisted method (Table 1). On the other hand,
when the ES cells cultured in either 1000 U/ml LIF alone
or 10 U/ml LIF plus BIO were aggregated with host dip-
loid embryos, the rates of 100% black coat-color in live
offsprings were  20–30% (Table 1). In the case of 10 U/
ml LIF-treated ES cells, all founder mice were entirely
derived from host ICR embryos (Table 1). These results
show that serum- and feeder-free B6 ES cells in 1000 U/
FIG. 2. Upregulation of self-renewal and pluripotency markers in serum- and feeder-free B6 ES cells stimulated by BIO treatment. (a) Scat-
ter plots showing a comparison of global gene expression between 1000 U/ml LIF alone and 1000 U/ml LIF plus 2 lM BIO culture condi-
tions, as determined by DNA microarrays (n 5 3). Lines indicate the linear equivalent and two-fold changes in gene expression levels
between the samples. (b) Quantitative RT-PCR analyses. Error bars are standard deviations (n 5 4). (c) Immunoﬂuorescence analyses of the
serum- and feeder-free B6 ES cells stained for Nanog and DAPI (nuclei). Scale bar: 50 lm.
418 SATO ET AL.ml LIF plus BIO combination cultures have high develop-
mental potency to contribute to founder mice.
The inhibition of the MEK pathway through the FGF
receptor was reported to suppress lineage commitment
even in the LIF absent condition (Burdon et al., 1999;
Hamazaki et al., 2006; Kunath et al., 2007), suggesting
that MEK inhibition promotes developmental potential
of ES cells. However, in our study, PD98059, which is a
known MEK inhibitor, did neither enhance the
production rate of 100% ES-derived founder mice nor
change the morphology of ES cells (Table 1 and Fig. S4).
Therefore, it appears that MEK inhibition is not required
for promoting the developmental potency of serum- and
feeder-free B6 ES cells.
ES-derived coat-color founder mice (100%) were also
efﬁciently generated from B6/129 F1 hybrid ES (V6.5)
cells under the serum- and feeder-free condition (8 100%
ES-derived coat-color mice/42 embryos transferred,
23.8%; Table 1 and Fig. S5). In our experiments, serum-
and feeder-free F1 hybrid ES cells in 1000 U/ml LIF plus
BIO medium exhibited round morphology and full devel-
opmental potential by the diploid aggregation method,
the same as inbred B6 ES cells. These results suggest that
regardless of the genetic background of the mouse
strain, a synergistic effect by LIF plus BIO treatment is
effective for enhancing the developmental potential in
various ES cells.
Next, we tested whether heterozygous mice were
directly obtained from gene-targeted B6 ES clones (Table
1). After electroporation of gene-targeting vectors, heter-
ozygous (1/2) clones were screened in the 1000 U/ml
LIF plus BIO medium under the serum- and feeder-free
condition. By aggregating those clones with each diploid
embryo, almost all heterozygous pups were stably born
with 100% black coat-color, and then exhibited full
germline transmission (Table 1). However, some clones
showed a loss of developmental potency due to abnor-
mal karyotypes (data not shown). Thus, serum- and
feeder-free ES cells cultured in 1000 U/ml LIF plus BIO
were not only able to generate heterozygous mice, but
also robust against genetic manipulation.
In addition, we successfully generated female B6 foun-
der mice by the aggregation of female (38 1 XO) B6 ES
cells with ICR eight-cell-stage diploid embryos. These
female mice with 100% black coat-color were fertile
(Table 1) and also available for in vitro fertilization (data
not shown).
Finally, to conﬁrm that 100% black coat-color founder
mice were fully derived from B6 ES cells treated with LIF
plus BIO, we assessed the contamination of host ICR
FIG. 3. Serum- and feeder-free B6 ES cells in LIF plus BIO have the ability to differentiate into the whole body. WT (1/1)( a and b left side)
and leptin receptor KO (2/2) (b right side) mice on B6 background were directly generated from WTand leptin receptor KO ES cells in 1000
U/ml LIF plus 2 lM BIO by aggregating with each eight-cell-stage diploid embryo. ICR mice were used as recipients for embryo transplanta-
tion. By using genomic DNA (c) and total RNA (d) of the founder mice, contamination of host ICR cells were examined with quantitative PCR
of the leptin receptor.
419 SERUM- AND FEEDER-FREE B6 ES CELLScells by quantitative PCR. For this analysis, we estab-
lished homozygotes (2/2) of leptin receptor targeting
in B6 ES cells cultured in 1000 U/ml LIF plus BIO under
the serum- and feeder-free condition (Fig. S6), and then
tested whether KO (2/2) founder mice were directly
generated from the KO (2/2) ES cells without the con-
tamination of host wild-type (1/1) cells. By aggregating
KO ES cells with one eight-cell-stage diploid embryo,
founder mice were born normally and developed to
adults with 100% black coat-color. Expectedly, the KO
ES-derived mice showed fatty bodies as same as db/db
mice (Fig. 3b). Quantitative PCR of the KO ES-derived
mice showed that Exon 1 of the leptin receptor was
completely deleted in the genomes of diverse tissues
(brain, liver, lung, heart, kidney, and small intestine)
(Fig. 3c). Consistent with these results, its transcription
was not detected in the brain and liver at all (Fig. 3d),
indicating that the founder mice generated from KO ES
cells were identical to KO mice. Taken together, we con-
cluded that serum- and feeder-free ES cells cultured in
LIF and BIO had a high capacity to differentiate into
the whole body. In addition, the direct generation of KO
ES-derived mice facilitated speedy phenotypic analyses
in vivo.
DISCUSSION
The treatment of LIF plus BIO dramatically changed the
morphology of serum- and feeder-free B6 ES cells and sig-
niﬁcantly increased the expressions of self-renewal and
pluripotency regulators. The aggregation or microinjec-
tion of serum- and feeder-free B6 ES cells cultured in LIF
plus BIO to each eight-cell-stage diploid embryo stably
provided germline-competent B6 ES-derived mice. Previ-
ously, it was reported that laser-assisted microinjection
of ES cells into an eight-cell-stage diploid embryo efﬁ-
ciently provides founder generation mice that are avail-
able for immediate phenotypic analyses (Poueymirou
et al., 2007). Certainly, the eight-cell-stage embryo
method is useful for obtaining ES-derived mice com-
pared to the conventional blastocyst injection method.
However, judging from the data in Table 1, the birth rate
of ES-derived mice seems to be highly dependent on the
developmental potential of ES cells regardless of embryo
manipulation. Accordingly, we hereby propose that se-
rum- and feeder-free ES cells cultured with LIF plus
GSK3 inhibitor are valuable for generating germline-
competent ES-derived mice.
It is accepted that B6 ES cells have low potency to col-
onize germ cells in their founder mice. In ES cell culture,
Nanog expression is thought to be an important factor
for the maintenance of germline competency. Compared
with LIF single-treated B6 ES cells, LIF plus BIO-treated
B6 ES cells showed homogeneous expression pattern of
Nanog (Fig. 2c). By aggregating them with each eight-
cell-stage diploid embryo, they stably differentiated into
germ cells in their founder mice, which exhibited full
germline transmission (Table 1). It has been reported
that Nanog is dispensable for expression of somatic plu-
ripotency but is speciﬁcally required for formation of
germ cells (Chambers et al., 2007). Moreover, by the
selection of Nanog expression, the germline-competent
induced pluripotent stem (iPS) cells have been success-
fully established from embryonic ﬁbroblasts (Okita
et al., 2007). From these ﬁndings, we speculate that ho-
mogeneous expression of Nanog is a landmark in ES cells
and/or iPS cells that have high potential to differentiate
particularly into germ cells.
ES cells have been reported to be maintained by three
inhibitors (3i) for FGF receptor and GSK3 (Ying et al.,
2008). For GSK3 inhibitors, BIO and CHIR99021 were
used in our study and that of Ying and colleagues,
respectively. After each treatment of GSK3 inhibitor, the
expression levels of Wnt/b-catenin target genes such as
Brachyury (T) and Cdx1 were similarly upregulated.
However, BIO treatment signiﬁcantly increased the
expression levels of Tbx3, Esrrb, and Tcl1 in B6-derived
ES cells, but CHIR99021 did not have the same upregula-
tion effect on these genes in 129-derived ES cells. More-
over, In addition to GSK3 inhibitor, we have used LIF in
KSR-based medium, while Ying’s group used two inhibi-
tors for the FGF receptor instead of LIF in N2B27-based
medium. In our studies, the LIF plus BIO combination
culture enhanced cell growth and developmental poten-
tial of serum- and feeder-free B6 ES cells as shown in Fig-
ure 1c and Table 1. Thus, different culture conditions
derived from different combinations of chemical com-
pounds, culture media, and ES cell strains may explain
these different ﬁndings. From the standpoint of stable
generation of founder mice, it is interesting for us to
examine which conditions bring out the best develop-
mental potential in each ES cell line, although GSK3
inhibition is crucial for ES cell culture.
Finally, diploid embryo aggregation with the serum-
and feeder-free B6 ES cells cultured in LIF plus GSK3 in-
hibitor is a rapid, cost-effective, and easy-to-learn method
for generating germline-competent B6 ES-derived foun-
der mice. Furthermore, GSK3 inhibition together with
LIF/STAT3 signaling makes it possible to enhance the de-
velopmental potential of various ES cells without spe-
ciﬁc skills and experience, because the serum lot check
and the preparation for feeder layers are skipped. Gener-
ally, in the conventional method, 129 or F1 hybrid ES
cells cultured in the presence of serum and feeder layers
have been used for the production of germline-compe-
tent chimeras. Partial chimeric mice generated from
these ES cells require multiple rounds of breeding to
produce homozygous mutations within a given mouse.
The desired mice are produced with a mixed genetic
background at low frequencies in the ﬁnal breeding
step. However, the use of B6 ES cell line instead of 129
or F1 hybrid ES cell line eliminates the need for back-
cross breeding. Founder mice entirely derived from
female XO, heterozygous, or homozygous mutant B6 ES
cells were directly available for intercross breeding and
phenotypic analysis in vivo. In addition, the access to
the public C57BL/6J mouse sequence and the RPCI23
C57BL/6J BAC genomic library is a powerful tool that
420 SATO ET AL.facilitates the production of gene-targeting vectors for
the manipulation of genes in C57/BL6 ES cell lines.
Therefore, from the point of view of saving time and
labor, the established serum- and feeder-free B6 ES cells
will be helpful and useful for large-scale functional




C57/BL6J ES cells (TB6-2) were originally established
by a previously published procedure (Shimizukawa
et al., 2005). By karyotyping, more than 90% of TB6-2
cells showed normal chromosome numbers (38 1 XY).
For serum-free cultures, we used Dulbecco’s Minimal
Essential Medium (DMEM) (Invitrogen) supplemented
with 25 mM D-glucose, 0.1 mM nonessential amino
acids, 1 mM sodium pyruvate, 0.1 mM 2 mercaptoetha-
nol, 4 mM L-glutamine, 100 U/ml penicillin, 100 lg/ml
streptomycin, 1000 U/ml LIF, and 15% KSR (Invitrogen).
Feeder-free ES cells were established from TB6-2 cells
cultured on MEF (Mouse Embryonic Fibroblast) cells. To
establish the feeder-free ES cells, the feeder-dependent
TB6-2 cells were cultured on a gelatin-coated plate in the
presence of LIF. After two passages under feeder-free
conditions, MEF cells were completely removed, and the
expanded ES cells were stocked. For inhibition of GSK3
and/or MEK activities, we used 2 lM of BIO (6-bromoin-
dirubin-30-oxime) (Calbiochem) and/or 40 lMo f
PD98059 (Calbiochem). The alkaline phosphatase assays
in ES cells were preformed by an alkaline phosphatase
detection kit (Chemicon). Cell growth in ES cells was
examined by a CellTitre-GloR Luminescent Cell Viability
assay (Promega). Female karyotype (XO) ES cells were
cloned by screening for Y chromosome deletion in XY
ES cells. The targeting in B6 ES cells was performed
under the feeder- and serum-free condition. Heterozy-
gous ES cells containing an attenuated neomycin phos-
photransferase gene (resistance to G418) under the con-
trol of the mouse phosphoglycerol kinase gene (PGK)
promoter were selected in 0.25 mg/ml of G418. After 9
days of selection culture, we picked up colonies and
screened heterozygous ES clones by PCR and Southern
blot analyses. Homozygous ES cells were obtained from
heterozygous ES cells by the selection culture at 1 mg/
ml (four times higher concentration) of G418
concentration.
DNA Construction
For Oct4-GIN vector construction, the Oct4 promoter
containing distal and proximal enhancer regions was
ampliﬁed from mouse genomic DNA by PCR. Primers
were as follows: forward, 50-ttctgtcgactctaggcacgcttaggc-
30 and reverse, 50-ttctagatctccgagccgggggcctggtgg-30.
The Oct4 promoter was inserted into a vector consisting
of a GFP-IRES-Neo.
Gene Expression Analysis
Total RNA was extracted by RNeasy kits (Qiagen). The
ﬁrst strand cDNA synthesis by reverse transcription was
performed with 0.25 lg of total RNA at 378Cf o r2h
using a high capacity cDNA archive kit (Applied Biosys-
tems) and subsequently diluted 10 times. Endogenous
mRNA levels of pluripotency markers (Oct4, Sox2,
Nanog, and Klf4) were measured with inventoried
TaqMan probes using an Applied Biosystems 7900HT
(Applied Biosystems). PCR primers and TaqMan probes
(50-FAM-30-Black hole Quencher, Biosearch); 50-FAM- or
50-VIC-Minor Groove Binder Non-Fluorescent Quencher
(MGBNFQ; Applied Biosystems) were used as follows:
leptin receptor forward, 50-cggagaccacgcaactt-30; leptin
receptor reverse, 50-ccccgggcagtttcca-30; leptin receptor
probe, 50-FAM-caggcctctgactact-MGBNFQ-30; b actin for-
ward, 50-aggtcatcactattggcaacga-30; b actin reverse, 50-
cacaggattccatacccaagaag-30; b actin probe, 50-VIC-
atgccctgaggctcttttccagcctt-MGBNFQ-30. GAPDH expres-
sion was examined by using Rodent GAPDH control
regents (Applied Biosystems). All results were normal-
ized to b actin or GAPDH expression. DNA microarrays
(Agilent) were performed with total RNAs from ES cells
treated with or without 2 lM of BIO for ﬁve days.
Immunoﬂuorescence Microscopy
ES cells were ﬁxed with 4% paraformaldehyde/PBS for
30 min at room temperature and permeabilized with
0.1% Triton X-100/PBS at room temperature for 30 min.
Primary and secondary antibodies were diluted to ﬁnal
working concentrations in 1% BSA, 0.1% TritonX-100/
PBS. Specimens were mounted with ProLong gold anti-
fade reagent containing DAPI (Molecular Probe). Images
of immunoﬂuorescent samples were obtained with a
Zeiss LSM510 confocal microscope. The ﬁnal concentra-
tions of antibodies were as follows: anti-b catenin-FITC,
1:250 (BD Bioscience); anti-Nanog, 1:250 (ReproCELL,
Tokyo, Japan); goat anti-rabbit IgG-FITC, 1/100
(Invitrogen).
Generation of Founder Mice
Two-cell-stage embryos were collected from oviducts
of plugged females at 1.5 dpc. After overnight incuba-
tion of the embryos at 378C/5% CO2 in Hepes-buffered
potassium simplex optimized medium (KSOM), zona
pellucidae of eight-cell-stage embryos were removed
with an acid-tyrode solution. The diploid embryos were
transferred into each KSOM drop. For aggregation, a
number of clumps of loosely connected ES cells were
selected under a dissecting microscope, and then one of
the ES cell clumps was put on the side of one embryo.
After overnight incubation at 378C/5% CO2 in KSOM,
the aggregated embryos were developed to the late mor-
ula/early blastocyst stage, and then transplanted into the
uterine horns of pseudo-pregnant ICR mice by the stand-
ard method. Conventional or laser-assisted microinjec-
tion was performed according to a previous report
(Poueymirou et al., 2007). A standard injection needle
421 SERUM- AND FEEDER-FREE B6 ES CELLSwas used to introduce 7–9 ES cells through a perforation
and into the perivitelline space. In laser-assisted microin-
jection, a XYClone laser system (Hamilton) was used to
make a perforation in the zona pellucida. The injected
eight-cell-stage embryos were cultured overnight at
378C/5% CO2 in KSOM before embryo transplantation.
All animal procedures were carried out according to the
Merck Worldwide Policy on Animal Care and Use.
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